Literature DB >> 33940284

Bacterial efflux transporters' polyspecificity - a gift and a curse?

Helen I Zgurskaya1, Giuliano Malloci2, Brinda Chandar3, Attilio V Vargiu2, Paolo Ruggerone2.   

Abstract

All mechanisms of clinical antibiotic resistance benefit from activities of polyspecific efflux pumps acting to reduce intracellular accumulation of toxins and antibiotics. In Gram-negative bacteria, the major polyspecific efflux transporters belong to the Resistance-Nodulation-cell Division (RND) superfamily of proteins, which are capable of expelling thousands of structurally diverse compounds. Recent structural and functional advances generated novel insights into mechanisms underlying the biochemical versatility of RND transporters. This opinion article reviews these mechanisms and discusses implications of the polyspecificity of RND transporters for bacterial survival and for the development of efflux pump inhibitors effective in clinics.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33940284      PMCID: PMC8169617          DOI: 10.1016/j.mib.2021.03.009

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.584


  59 in total

Review 1.  Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.

Authors:  K Poole
Journal:  J Mol Microbiol Biotechnol       Date:  2001-04

Review 2.  RND efflux pumps: structural information translated into function and inhibition mechanisms.

Authors:  Paolo Ruggerone; Satoshi Murakami; Klaas M Pos; Attilio V Vargiu
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 3.  Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.

Authors:  Jingjing Sun; Ziqing Deng; Aixin Yan
Journal:  Biochem Biophys Res Commun       Date:  2014-05-27       Impact factor: 3.575

4.  Drug Permeation against Efflux by Two Transporters.

Authors:  Paramita Saha; Samapan Sikdar; Ganesh Krishnamoorthy; Helen I Zgurskaya; Valentin V Rybenkov
Journal:  ACS Infect Dis       Date:  2020-02-25       Impact factor: 5.084

5.  Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump.

Authors:  Alfred D Kinana; Attilio V Vargiu; Thithiwat May; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

6.  Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa.

Authors:  O Lomovskaya; A Lee; K Hoshino; H Ishida; A Mistry; M S Warren; E Boyer; S Chamberland; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; H Tsujimoto; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

8.  Binding and Transport of Carboxylated Drugs by the Multidrug Transporter AcrB.

Authors:  Heng-Keat Tam; Viveka N Malviya; Wuen-Ee Foong; Andrea Herrmann; Giuliano Malloci; Paolo Ruggerone; Attilio V Vargiu; Klaas M Pos
Journal:  J Mol Biol       Date:  2019-12-25       Impact factor: 5.469

Review 9.  Structural and Functional Diversity of Resistance-Nodulation-Cell Division Transporters.

Authors:  Philip A Klenotic; Mitchell A Moseng; Christopher E Morgan; Edward W Yu
Journal:  Chem Rev       Date:  2020-11-19       Impact factor: 60.622

10.  Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.

Authors:  Elizabeth M Grimsey; Chiara Fais; Robert L Marshall; Vito Ricci; Maria Laura Ciusa; Jack W Stone; Alasdair Ivens; Giuliano Malloci; Paolo Ruggerone; Attilio V Vargiu; Laura J V Piddock
Journal:  mBio       Date:  2020-06-02       Impact factor: 7.867

View more
  7 in total

1.  Recognition of quinolone antibiotics by the multidrug efflux transporter MexB of Pseudomonas aeruginosa.

Authors:  Silvia Gervasoni; Giuliano Malloci; Andrea Bosin; Attilio V Vargiu; Helen I Zgurskaya; Paolo Ruggerone
Journal:  Phys Chem Chem Phys       Date:  2022-07-13       Impact factor: 3.945

2.  Molecular rationale for the impairment of the MexAB-OprM efflux pump by a single mutation in MexA.

Authors:  Pierpaolo Cacciotto; Andrea Basciu; Francesco Oliva; Giuliano Malloci; Martin Zacharias; Paolo Ruggerone; Attilio V Vargiu
Journal:  Comput Struct Biotechnol J       Date:  2021-12-03       Impact factor: 7.271

3.  Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.

Authors:  Coline Plé; Heng-Keat Tam; Anais Vieira Da Cruz; Nina Compagne; Juan-Carlos Jiménez-Castellanos; Reinke T Müller; Elizabeth Pradel; Wuen Ee Foong; Giuliano Malloci; Alexia Ballée; Moritz A Kirchner; Parisa Moshfegh; Adrien Herledan; Andrea Herrmann; Benoit Deprez; Nicolas Willand; Attilio Vittorio Vargiu; Klaas M Pos; Marion Flipo; Ruben C Hartkoorn
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

4.  Role of Efflux Pump-Mediated Antibiotic Resistance in Quorum Sensing-Regulated Biofilm Formation by Salmonella Typhimurium.

Authors:  Jirapat Dawan; Yinyue Li; Feng Lu; Xinlong He; Juhee Ahn
Journal:  Pathogens       Date:  2022-01-24

5.  AB-DB: Force-Field parameters, MD trajectories, QM-based data, and Descriptors of Antimicrobials.

Authors:  Silvia Gervasoni; Giuliano Malloci; Andrea Bosin; Attilio V Vargiu; Helen I Zgurskaya; Paolo Ruggerone
Journal:  Sci Data       Date:  2022-04-01       Impact factor: 6.444

6.  Impact of Bacillus subtilis Antibiotic Bacilysin and Campylobacter jejuni Efflux Pumps on Pathogen Survival in Mixed Biofilms.

Authors:  A Erega; P Stefanic; T Danevčič; S Smole Možina; I Mandic Mulec
Journal:  Microbiol Spectr       Date:  2022-08-08

Review 7.  Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time.

Authors:  Martijn Zwama; Kunihiko Nishino
Journal:  Antibiotics (Basel)       Date:  2021-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.